These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24669604)

  • 1. Efficacy of telmisartan and atenolol in management of essential hypertension.
    Khan P; Khan W; Abbasi A; Ahad A; Khan M; Ahmad Y; Ahmad A
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):36-8. PubMed ID: 24669604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
    Alcocer L; Fernández-Bonetti P; Campos E; Olvera Ruiz R; Bahena J; de la Fuente JJ; Segovia-Ayala C; Dominguez-Henkel R
    Int J Clin Pract Suppl; 2004 Dec; (145):35-9. PubMed ID: 15617457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
    Zhang ZL; Li HL; Wen ZP; Yang GP; Zhang W; Chen XP
    Chin Med J (Engl); 2016 Jan; 129(1):8-14. PubMed ID: 26712426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
    Higaki J; Komuro I; Shiki K; Lee G; Taniguchi A; Ikeda H; Kuroki D; Nishimura S; Ogihara T
    Hypertens Res; 2017 Mar; 40(3):251-258. PubMed ID: 27761000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan.
    McClellan KJ; Markham A
    Drugs; 1998 Dec; 56(6):1039-44; discussion 1045-6. PubMed ID: 9878991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
    Neldam S; Schumacher H; Guthrie R
    Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
    Neldam S; Schumacher H; Kjeldsen SE; Neutel JM
    Curr Med Res Opin; 2014 Sep; 30(9):1715-24. PubMed ID: 24834808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.
    Amerena J; Pappas S; Ouellet JP; Williams L; O'Shaughnessy D
    J Int Med Res; 2002; 30(6):543-52. PubMed ID: 12526280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
    J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.